The future of medical cannabis research and its place in clinical practice w Dr. Dedi Meiri

Join Dr. Dedi Meiri, from the Laboratory of Cancer Biology and Cannabinoid Research at the Technion, as he shares his current research into cannabis for various medical applications.

Dedi will be interviewed by Adam Miller, Founder and Board member at the Medical Canabis Council and Head of Strategic Accounts at MediPharm Labs – MediPharm Labs are specialists in cannabis extraction and purification.

Date: Wednesday, 20 May
Time: 7pm – 8pm* (Syd / Melb) – * 12pm – 1pm (Israel)
LIVE on ZOOM and FACEBOOK

Dr. Meiri is among the world’s leading scientists dedicated to studying and understanding the very real healing properties of one of the world’s oldest medicinal plants, cannabis – including how it might help in the fight against COVID-19.

Cannabis, was first prescribed by the name, ‘Ma’ in 2700 BCE by Chinese healers. What these ancient healers didn’t know about cannabis, is that there are 144 unique strains of phytocannabinoids, aside from the more common CBD and THC strains.

Dr. Meiri and his team have been diligently working on isolating and categorising these 144 individual cannabinoid strains, quite simply so that their healing potential can be further understood.